Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Russia is taking over Nestlé's domestic assets 🍫 Shares are down nearly 3% 💥
Market warp: Rate Forecasts and Semiconductors in the Spotlight
Daily Summary: Hawkish Fed fails to scare the markets (17.09.2026)
Nasdaq 100 Up 1.7%